Delivery Order SPE2DB20D2104-SPE2DB25FMAXF
Award Date
10/18/24
Potential Completion Date
10/21/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, is for the delivery of the drug Mounjaro (2.5 mg/0.5 ml pen). The $3,419.00 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 22, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to...
This federal contract award, valued at $1,578.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor. The contract is for the delivery of the medication Mounjaro (12.5 mg/0.5 ml pen, 0.5 ml) to support military treatment facilities and programs. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is September 13, 2024. The contract is not designated as a set-aside....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of the drug Mounjaro (10 mg/0.5 ml pen, 0.5 ml) with a ceiling value of $10,520.00 and a completion date of September 23, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026, which provides a comprehensive range...
This federal contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, provides for the delivery of the medication Mounjaro 5 mg/0.5 ml pen (0.5 ml) to the Defense Logistics Agency (DLA). The $3,304.32 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities to support military treatment...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a medical product. The $1,351.23 firm fixed price delivery order is funded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of June 30, 2025 and was awarded on June 27, 2025. The contract is not set-aside and indicates open competition. As a large prime contractor, Amerisourcebergen Drug Corp...
This federal contract award, valued at $1,052.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide the drug Mounjaro (2.5 mg/0.5 ml pen, 0.5 ml) to support the Department of Defense (DoD). The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Mounjaro 10 mg/0.5 ml pen (0.5 ml). The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $12,739.21 and an ultimate completion date of October 17, 2024. The contract is a delivery order with a firm fixed-price pricing type and does not have a set-aside designation. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with...
This federal contract award is for delivery of the pharmaceutical product Mounjaro (7.5 mg/0.5 mL pen) to the Defense Logistics Agency (DLA). The $36,978.47 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 24, 2024, with a completion date of October 25, 2024. The contract is a delivery order, not associated with a set-aside designation, and is part of AmerisourceBergen's broader $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,447.12, is a delivery order to supply the medication Mounjaro (5 mg/0.5 ml pen) for the DLA. The contract has a ceiling value of $5,447.12 and a period of performance through February 28, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Mounjaro (5 mg/0.5 ml pen, 0.5 ml) with a ceiling value of $3,209.65 and an ultimate completion date of October 10, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...